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Acute lung injuryAbstract The study aimed to explore the protective effects of AS-IV against sepsis-induced ALI.
Sepsis was induced by cecal ligation and puncture (CLP) method in Sprague Dawley rats. Rats were
randomly assigned into five groups: animals undergoing a sham CLP (sham group); animals under-
going CLP (CLP group); animals undergoing CLP and treated with AS-IV at 2.5 mg/kg bw (low-
dose AS-IV [L-AS] group), at 5 mg/kg bw (mid-dose AS-IV [M-AS] group), and at 10 mg/kg bw
(high-dose AS-IV [H-AS] group). At 6 h, 12 h and 24 h post-CLP surgery, six rats were respectively
sacrificed to collect blood and lung tissue samples. The levels of arterial blood gas index, lung water
content, protein level and leukocyte counts (total amount, neutrophils and lymphocytes) in bron-
choalveolar lavage fluid (BALF) and cytokines such as TNF-a and IL-6 in BALF were measured
at each time point in different groups. HE-staining and optical microscopy were performed to
examine the pathological changes in lungs. The 72 h-survival rate of each group was also recorded.
PaO2 was decreased significantly, while the lung water content, BALF protein level, cell numbers,
BALF cytokine TNF-a and IL-6 levels were increased significantly for CLP group as compared
with sham group. Moreover, pathological injury was observed in lung tissue indicating the success-
ful sepsis-induced ALI model. Speaking of the effect of AS-IV, we founded that, compared with the
CLP group, the AS-IV treatment groups could significantly alleviate all the above negative changes
exited in the CLP group in a dose-dependent manner. What’s more, the pathological injury was also
gradually improved by AS-IV treatment compared with the CLP rats. AS-IV exerts its protective
effect against sepsis-induced ALI in rats via improving pulmonary ventilation function, decreasing
the permeability of alveolar epithelium and capillary as well as repressing lung inflammation.
 2016 The Authors. Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sepsis, a common complication of burn, trauma, hypoxia, and
post-surgery, is a systemic inflammatory response syndrome
caused by infection (Tjardes and Neugebauer, 2002; Lever
and Mackenzie, 2007). With relatively high morbidity mortal-
ity, sepsis is considered to be the leading cause of death of
patient in the intensive care unit (ICU) (Tjardes and
Neugebauer, 2002; Levy et al., 2001; Angus and van der
342 R. Huang, M. LiPoll, 2013). Multiple organ function impairment may occur at
severe sepsis and ultimately develop to multiple organ dysfunc-
tion syndrome (Marshould, 2001). Lung is one of the most vul-
nerable organs at sepsis with acute lung injury (ALI)/acute
respiratory distress syndrome (ARDS) which occurs at early
stage and is with high morbidity (Hudson et al., 1995; Husak
et al., 2010; Angus et al., 2001). The severe pulmonary inflam-
mation, vascular permeability, diffuses infiltration in both
lungs, and pulmonary alveoli edema, hypoxemia and
lung compliance decrease are the characteristics for ALI
(Villar et al., 2011). Both intra pulmonary factors and extrinsic
pulmonary factors make contribution to the pathogenesis of
ALI/ARDS. The intra factors include aspiration pneumonia,
severe diffuse lung infection, pulmonary contusion, and
extrinsic factors include sepsis caused by extrinsic pulmonary
infection, wound shock and burn (Brun-Buisson et al., 2004;
Gattinoni et al., 1998; Sheu et al., 2010). Among these, sepsis
is the most common cause of ALI (Suntharalingam et al.,
2001; Rocco and Zin, 2005). Currently, there are still no effec-
tive drugs and therapies for the treatment of sepsis-associated
ALI/ARDS. The main method is supportive treatment such as
mechanical ventilation for respiration support. However,
increasing evidence has demonstrated that mechanical ventila-
tion brings damage to organs when improving the oxygenation
for the patients. Mechanical tension caused by excessive
mechanical ventilation, is an important cause for lung injury
(Rocco and Zin, 2005; Martin et al., 2003) and could often
cause inflammation in lungs. Therefore, development for new
method of curing ALI caused by sepsis other than mechani-
cal ventilation is imperative.
Astragaloside IV (AS-IV) is a saponin separated from
astragalus with wide biological and pharmacological activity.
Pharmacological experiments showed that AS-IV has protec-
tive effects, such as anti-inflammation (Zhang et al., 2003;
Gui et al., 2013), antioxidant (Gui et al., 2012) anti-brain
infarction, neuro-protection (Luo et al., 2004; Cheng et al.,
2006), anti-hypertension (Zhang et al., 2006), and myocardial
protection (Li and Cao, 2002). However, there are only a
few researches about the effect of AS-IV on lung injury.
Xiong et al. (2010) found AS-IV is protective for rat pul-
monary ischemia–reperfusion lung injuries. Chen et al.
(2016) thought AS-IV exerted the protective effect for para-
quat induced rat lung injuries by restraining Rho/ROCK/
NF-jB signal pathway. This study aimed to seek the effect
of AS-IV on ALI through further research on the sepsis ALI
rat model.
2. Materials and methods
2.1. Reagent and animals
Astragaloside IV was purchased from Shrqbio Co. Ltd.
(Shanghai, China, purity P98%). BCA Protein Assay Kit,
rat TNF-a and IL-6 ELISA kits were purchased from Wuhan
Boster Bio-Engineering Co. Ltd. (Wuhan, China).
Healthy male Sprague Dawley rats (200 ± 20 g) were pur-
chased from Guangdong Medical Laboratory Animal Center
(Guangdong, China). All animals were raised at SPF labora-
tory animal room with a 12 h light/dark cycle at 24 ± 2 C
and 40–70% humidity. Animals were allowed to have free
access to water and food during experiment period. All animalexperiment operations were conducted according to nursing
and use guidance for animal experiment operation of National
Institutes of Health.
2.2. Animal groups
After a period of adaptation, ninety SD rats were selected and
divided into five random groups (n= 20 per group): sham
group, CLP control group, low-dose AS-IV (L-AS) group,
middle-dose AS-IV (M-AS) group, and high-dose AS-IV
(H-AS) group. The AS-IV was diluted into three different
concentrations with 1% carboxymethyl cellulose (CMC). The
L-AS, M-AS and H-AS groups were administrated with
AS-IV by gavage at the dosages of 2.5 mg/kg bw, 5 mg/kg bw
and 10 mg/kg bw, respectively, while the sham group and
sepsis model group were gavaged with 1% CMC at the same
volume. The indicators determined in this study were observed
at three time points (6 h, 12 h and 24 h post-CLP), and each
time six rats were used. Another fifty SD rats were distributed
into the same five groups as above for the observation of
survival rate.
2.3. Acute lung injury molding
Sepsis was introduced by CLP technique as described previ-
ously (Ritter et al., 2003; Sener et al., 2005). Briefly, after a
12-h deprivation of food but not water, the rats were generally
anesthetized with chloral hydrate anesthesia (0.3 ml/100 g bw),
and then a midline abdominal incision was made to expose the
cecum. After a cecal ligation treatment, an 18-gauge needle
was used to puncture through the central segment of ligation,
and a small amount of cecal contents was squeezed out
through the puncture wound. Then, the cecum was restored
into the abdominal cavity and the surgical incision was sutured
layer by layer. In sham group rats, the cecum was exposed and
the bowel was massaged as described above, but it was not
ligated or punctured.
2.4. Aortic blood-gas analyses
Six animals were sacrificed 6 h, 12 h and 24 h after CLP,
respectively, by intraperitoneal injection of chloral hydrate
(0.3 ml/100 g bw) for general anesthesia. Blood samples of
2 ml were obtained from aorta abdominals for arterial blood
gas analyses by automatic blood gas analyzer (America Nova
Company, Nova-K type).
2.5. Dry/wet ratio of lung
Right upper pulmonary lobe was excised, blotted dry and
weighed, and then placed in an oven at 70 C for 48 h to obtain
the dry weight. The ratio of the wet lung to the dry lung was
calculated to assess tissue edema.
2.6. Histopathology observation
Right lower lobe was taken from the animals which had been
executed after 6 h, 12 h and 24 h of CLP respectively. After
being washed wash with saline solution, the organ was fixed
by formalin to make paraffin section. The pathological
Figure 1 AS-IV increased PaO2 in CLP-induced ALI rats. Data
are presented as mean ± SD, n= 6. *P< 0.05 compared with
sham rats and #P< 0.05, compared with CLP rats.
Figure 2 AS-IV reduced lung W/D ratio in CLP-induced ALI
rats. Data are presented as mean ± SD, n= 6. *P< 0.05
compared with sham rats and #P< 0.05 compared with CLP rats.
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scope after hematoxylin and eosin staining.
Four fields at 200 magnification were randomly selected
from each lung tissue section and six sections were randomly
chosen from each mouse. Two investigators blinded to group
assignments analyzed the samples and determined levels of
lung injury according to the semiquantitative scoring outlined
below. The degree of lung injury was evaluated using a five-
grade method described by Franco as follows: 1. Normal; 2.
Interstitial inflammatory cell infiltration <50%; 3. Interstitial
inflammatory cell infiltration >50%; 4. Consolidation of lung
and inflammatory cell infiltration <50%; 5. Consolidation of
lung and inflammatory cell infiltration >50%. The mean score
was used for comparison between groups.
2.7. Measurement of protein content, cytokine and cell counting
in the BALF
Left lung was obtained and lavaged by 0.5 ml saline from the
bronchus alveolar for 4 times. And then, the BALF was
collected and centrifuged for 10 min with the speed of
2500 r/min at room temperature. Supernatant was collected
and stored at 80 C for the measurement of protein content
and inflammatory mediators such as TNF-a and IL-6, while
the sediment was used for the leukocyte differential counting.
The protein content was determined by the method of BCA
and level of TNF-a and IL-6 was tested with corresponding
ELISA kit. The BALF cell sediment was re-suspended in
0.1 ml of saline, centrifuged onto slides and stained for 8 min
with Wright–Giemsa staining. Differential cell counting for
neutrophil and lymphocyte was conducted through quantifica-
tion of the slides by counting a total of 200 cells/slide at 40*
magnification.
2.8. Survival study
The rat’s survival rates were recorded at 72 h in another exper-
iment (n= 10 per group) as mentioned above to confirm
whether AS-IV treatment would confer protection against
sepsis-induced ALI. And pathological autopsy was done for
the dead rats to observe the definite symptoms.
2.9. Statistical analysis
Statistical analysis of data was performed by Graph Pad Pris-
m5.00 and all data were expressed as means ± SD. Changes of
different groups were compared by the method of one-way
ANOVA. The survival rate curve should be analyzed by log-
rank. A P value < 0.05 was considered statistically significant.
3. Results
3.1. Effect of AS-IV on the aorta blood oxygen pressure of CLP-
induced ALI rat
As demonstrated in Fig. 1, the PaO2 of CLP group at every
time point was significantly lower than the sham group
(P< 0.05), indicating the pulmonary gas exchange function
of rats in CLP group was significantly decreased. And com-
pared with CLP group, PaO2 of the three AS-IV treatmentgroups was significantly increased (P< 0.05) in a dose-
dependent manner. The result demonstrated that AS-IV had
an obvious improving effect on the gas exchange function of
lung.
3.2. Effect of AS-IV on the lung water content of CLP-induced
ALI rat
As shown in Fig. 2, the lung water content in CLP group was
significantly increased (P< 0.05) at every time point com-
pared with sham group, indicating the severe pulmonary ede-
ma in CLP group. When it comes with the AS-IV treatment
groups, at 6 and 12 h post-CLP, lung water content of M-AS
and H-AS group was significantly lower (P< 0.05) than
CLP group, while there was no obvious difference for the lung
water content (P> 0.05) between the L-AS group and CLP
group. When at 24 h post-CLP, lung water content of the three
AS-IV treatment groups was all significantly lower (P< 0.05)
than that of CLP group.
Figure 4 AS-IV inhibited TNF-a and IL-6 expression in the
BALF of CLP-induced ALI rats. Data are presented as mean
± SD, n= 6. *P< 0.05 compared with sham rats and #P< 0.05
compared with CLP rats.
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induced ALI rat
As demonstrated in Fig. 3, the BALF protein content in CLP
group at each time point was markedly higher (P< 0.05) than
that of sham group, which indicated that, after lung injury, the
obvious capillary permeability of alveolar led to leakage of
protein. Speaking of the effect of AS-IV, all of the three AS-
IV treatment groups showed varying degrees’ decrease
(P< 0.05) on the level of BALF protein compared with
CLP group.
3.4. Effect of AS-IV on the BALF cell cytokine of CLP-induced
ALI rat
BALF cell cytokine levels of TNF-a and IL-6 were detected to
investigate the effect of AS-IV on the BALF Cell Cytokine
secretion. As shown in Fig. 4(A), TNF-a level of CLP group
rats at each time point increased significantly (P< 0.05) com-
pared with the sham group, reaching its peak 6 h after CLP
surgery and then declining gradually over time. Speaking of
the effect of AS-IV treatment, only the TNF-a level in H-AS
group was significantly decreased (P< 0.05) at all of the three
time points. From Fig. 4(B) we found that, IL-6 level of rats in
CLP group at each time point was notably higher than that in
sham group (P< 0.05), and grew with the time, finally reach-
ing its peak at 24 h after CLP surgery. At 6 h post-CLP, there
was no significant difference (P> 0.05) between all of the
three dose AS-IV groups and CLP group. When it comes to
the time points of 12 and 24 h after operation, the IL-6 level
in H-AS group and M-AS group was significantly decreased
(P< 0.05) compared with CLP group, while there was no sig-
nificant difference for IL-6 level between L-As group and CLP
group (P> 0.05).
3.5. Effect of AS-IV on the BALF inflammation cell counting
As shown in Fig. 5, the total BALF cell amount, neu-
trophil granulocyte and lymph cell counting of CLP at eachFigure 3 AS-IV decreased the amount of protein in the BALF of
CLP-induced ALI rats. Data are presented as mean ± SD, n= 6.
*P< 0.05 compared with sham rats and #P< 0.05 compared
with CLP rats.time point were significantly higher than those of sham group
(P< 0.05). And compared with CLP group, the BALF total
cells, neutrophils and lymphocytes in AS-IV treated groups
decreased remarkably at each time point and the differences
were of statistical significance (P< 0.05).
3.6. Effect of AS-IV on pulmonary morphology
Histopathological examination (Fig. 6) showed that, the lung
tissue of rats in sham group was morphologically normal at
6, 12 and 24 h post-CLP, without broadening of alveolar sep-
tum, inflammation cell in alveolar cavity and leakage of inter-
stitial fluid. But compared with the sham groups, severe
damage on the pulmonary alveoli structure was observed for
all of the CLP and AS-IV-treated groups, with the appearance
of histopathological changes such as complete destruction of
pulmonary alveoli structure, pulmonary edema, inflammation
cell infiltration, pulmonary vascular congestion and hemor-
rhage. And the harm was more and more serious over time.
AS-IV-treated groups gradually alleviated the pulmonary alve-
oli damage by increase in dosage administration. In terms of
pulmonary morphology at each time point, the grading result
of lung tissue pathology indicated that the lung tissue pathol-
ogy grade for CLP was always remarkably higher than the
sham group (all is P< 0.01). The lung tissue pathology grad-
ing of H-As and M-As group fell significantly as compared
with CLP group (P< 0.05; P< 0.01; P< 0.01). However,
Figure 5 AS-IV reduced the number of total cells, neutrophils
and lymphocytes in the BALF of CLP-induced ALI rats. Data are
presented as mean ± SD, n= 6. *P< 0.05 compared with sham
rats and #P< 0.05 compared with CLP rats.
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and CLP group (all is P> 0.05). The pulmonary morphology
results indicated that the AS-IV could inhibit the pathological
damage of lung tissue for the sepsis rat in a dose-dependent.
3.7. Effect of AS-IV on survival rate
As demonstrated in Fig. 7, the survival rates of CLP group and
L-As group were 40% and 60%, respectively, which were sig-
nificantly different (P< 0.01; P< 0.05) compared with the
sham group. Although the 72 h survival rate of L-As group
was higher than CLP group there was no statistical significance
(P> 0.05). The 72 h survival rates for M-As and H-As group
were 80% and 90%, respectively and 40% and 50% (P< 0.05;
P< 0.05) higher than the CLP group. Moreover, there were
no significant differences for the 72 h survival rates betweenM-As, H-As group and sham group (P> 0.05; P> 0.05).
The result indicated that both the AS-IV median/high dose
could effectively raise the 72 h survival rate of rat with acute
lung injury.
Meanwhile, hemorrhagic odor exudation in the abdominal
cavity, flatulence in small intestine, swelling, darkening, necro-
sis, adhesion at cecal of ligation end, and obvious lung conges-
tion were found through pathological autopsy for the dead rat.
And the symptoms of animals in the three AS-IV treatment
groups were lighter than CLP group which indicated AS-IV
had a protective effect on sepsis acute lung injury rat.
4. Discussion
Sepsis, the clinic syndrome of extreme high morbidity rate and
mortality, is regarded as the first cause of death for ICU
patient. The lung is one of the most vulnerable target organs
and ALI induced by sepsis is one of the major causes for death
(Brun-Buisson et al., 2004; Gattinoni et al., 1998). Natural
products have long been used to prevent and treat diseases,
including inflammatory and immune-related disease. Recent
research has found that the AS-IV, which is the natural com-
pound extracted from a traditional Chinese herb Astragalus
membranaceus, has protective effect for rat pulmonary ische-
mia–reperfusion lung injuries (Xiong et al., 2010; Chen et al.,
2016). So, the present study aimed to investigate whether
AS-IV has the ability of protecting rats of ALI associated with
sepsis and improving pathophysiologic changes in sepsis-
induced ALI.
As we know, early responses for CLP (sluggish response,
activity decrease, excretion at oral cavity and eye, watery stool,
shiver and body temperature decrease) occurred in rat after 6 h
of operation, and the obvious inflammatory responses (extrin-
sic allergic alveolitis, alveolar hemorrhage and pulmonary
edema) came at 12 h after operation, and then lethality
occurred around 18 h after operation, reaching peak after
24 h. And considering that, restorative change happened after
72 h by rat resumed intake of food and water, increase in activ-
ity, gradual alleviation of pathological change, this research
chose three time points at 6 h, 12 h, and 24 h after CLP oper-
ation for sampling and observed 72 h survival rate combined
with general condition change, pulmonary inflammation cell
infiltration, pulmonary alveoli blood capillary membrane per-
meability increase and pulmonary congestion, hemorrhage
change and time related change pattern.
Firstly, we examined the function of AS-IV on lung air
exchange in sepsis-induced ALI. The air exchange is the most
important function for the lung. The change of pulmonary
ventilation function is the important basis for evaluation of
ALI progress. ALI will lead to the drop of pulmonary volume,
compliance, imbalance of ventilation/perfusion ratio, and oxy-
genation damage, which characterized clinically symptoms as
refractory hypoxemia. PaO2 is a simple and effective objective
evidence for the evaluation of lung air exchange function (El-
Khatib and Jamaleddine, 2004). Therefore, this study adopted
PaO2 to evaluate the change of lung air exchange of each
group. The result showed that the PaO2 was ameliorated by
all of the three AS-IV treatment groups, indicating that the
AS-IV could improve the lung air exchange function.
Then, the effect of AS-IV on lung epithelial permeability
and microvascular permeability in sepsis-induced ALI rats
Figure 6 AS-IV ameliorated histopathological changes in lung tissues of CLP-induced ALI rats. (A) Representative images of
hematoxylin and eosin (H&E) staining from each experimental group at 6 h, 12 h and 24 h after CLP. Original magnification, (B) mean
histopathological lung injury scores 6 h, 12 h and 24 h after CLP. Data are presented as mean ± SD, n= 6. *P< 0.05, **P< 0.01
compared with sham rats and #P< 0.05, ##P< 0.01 compared with CLP rats.
Figure 7 AS-IV increased the 72 h survival curves of CLP-
induced ALI rats, n= 10 for each group. *P< 0.05, **P< 0.01
compared with sham rats and #P< 0.05 compared with CLP rats.
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permeability of lung epithelial and capillaries micrangium
caused by lung epithelial and capillaries micrangium cell dam-
age. The failure of normal fluid exudation and resorption
could cause pulmonary edema. Abnormal increase in vascular
permeability would result in permeation of macromolecule
protein beyond the blood vessel, which led to increase of pro-
tein in alveoli and pulmonary interstitium (Perl et al., 2011). Inthis research, pulmonary water and protein content of BALF
were both adopted to evaluate the change of permeability of
lung epithelial and capillaries micrangium. The result showed
that the AS-IV could significantly reduce the pulmonary water
and BALF protein contents of sepsis-induced ALI rats, indi-
cating that the AS-IV is capable of alleviating the permeability
of lung epithelial and capillaries micrangium.
Also, indicators of inflammation reaction were detected in
this study, since ALI is considered as the manifestation of sys-
tematic inflammation at lung. The occurrence of pro-
inflammatory cell factor in the early stage of inflammation
reaction is important for lung injury at late stage (Lotze and
Tracey, 2005; Marques-Rocha et al., 2015). This research
detected the level of TNF-a and IL-6 which are the mediators
of inflammation reaction (Marques-Rocha et al., 2015; Siebert
et al., 2015).
The result showed that AS-IV could remarkably reduce the
level of inflammation factor TNF-a and IL-6 of CLP-induced
ALI rats. In addition, the ALI would lead to activation and
accumulation of lung inflammation cell to generate the
enhanced infection cell factor and expedite the permeability
of alveolar blood capillary. This research has found that AS-
IV could reduce the total amount of leukocyte, the amount
of neutrophile granulocyte and lymph cell. The pathological
stain of pulmonary morphology indicated that AS-IV could
Protective effect of Astragaloside IV 347effectively restrain the pathological changes of pulmonary
edema, inflammation reaction, pulmonary vascular congestion
and hemorrhage. These results were consistent with the
previous reports in literatures, indicating that AS-IV could
effectively alleviate the lung inflammation reaction of CLP-
induced ALI rats and more effective with higher dosage
(Xiong et al., 2010; Chen et al., 2016). However, the specific
signal pathway that is affected by AS-IV to restrain the lung
inflammation reaction is yet to be further elaborated.
5. Conclusion
In summary, this research revealed that AS-IV could protect
sepsis-induced ALI rats from lung injury by improving lung
air exchange, restraining the change of lung epithelial perme-
ability and pulmonary microvascular permeability, lowering
lung inflammation reaction and alleviating lung pathological
damage injury, which eventually raised the survival rate of
sepsis-induced ALI rats.
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